<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Int J Reprod Biomed (Yazd)</journal-id><journal-id journal-id-type="iso-abbrev">Int J Reprod Biomed (Yazd)</journal-id><journal-id journal-id-type="publisher-id">IJRB</journal-id><journal-title-group><journal-title>International Journal of Reproductive Biomedicine</journal-title></journal-title-group><issn pub-type="ppub">2476-4108</issn><issn pub-type="epub">2476-3772</issn><publisher><publisher-name>Research and Clinical Center for Infertility</publisher-name><publisher-loc>Yazd, Iran</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">29177240</article-id><article-id pub-id-type="pmc">5605859</article-id><article-id pub-id-type="publisher-id">ijrb-15-375</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Polycystic ovary syndrome and circulating inflammatory markers</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Zafari Zangeneh</surname><given-names>Farideh</given-names></name><degrees>Ph.D.</degrees><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Naghizadeh</surname><given-names>Mohammad Mehdi</given-names></name><degrees>M.Sc.</degrees><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Masoumi</surname><given-names>Masoumeh</given-names></name><degrees>M.Sc.</degrees><xref ref-type="aff" rid="aff1">1</xref></contrib></contrib-group><aff id="aff1">
<label>1</label>
<italic>Reproductive Health Research Center, Tehran University of Medical Sciences, Tehran, Iran</italic>
</aff><aff id="aff2">
<label>2</label>
<italic>Noncommunicable Diseases Research, Fasa University of Medical Sciences, Fasa, Iran.</italic>
</aff><author-notes><corresp id="cor">Corresponding Author: Farideh Zafari Zangeneh, Vali-Asr Reproductive Health Research Center, Imam Hospital Complex, Tehran, Iran. Post Cod: 14197333041, Email: zangeneh14@gmail.com ,Tel: (+98) (21 66581616)</corresp></author-notes><pub-date pub-type="ppub"><month>6</month><year>2017</year></pub-date><volume>15</volume><issue>6</issue><fpage>375</fpage><lpage>382</lpage><history><date date-type="received"><day>28</day><month>6</month><year>2016</year></date><date date-type="rev-recd"><day>10</day><month>12</month><year>2016</year></date><date date-type="accepted"><day>10</day><month>5</month><year>2017</year></date></history><permissions><license license-type="open-access"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/3.0/">http://creativecommons.org/licenses/by/3.0/</ext-link>) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><sec><title>Background:</title><p>Human and experimental studies suggest that the sympathetic regulatory drive in the ovary may be unbalanced (hyperactivity) in polycystic ovary syndrome (PCOS). Dysfunctional secretion of interleukin (IL) -1 (&#x003b1; &#x00026; &#x003b2;) or related cytokines may thus be related to abnormal ovulation and luteinization.</p></sec><sec><title>Objective:</title><p>The aim of this study was the evaluation of cytokines&#x02019; pattern in PCOS women and discussion about the explanation of cross-talk between two super systems: sympathetic and immune systems and explanation sympatho-excitation and relationship with interleukins.</p></sec><sec><title>Materials and Methods:</title><p> In this study, 171 PCOS women aged between 20-40 years were studied the. Their body mass index was &#x0003c;28. The patients were divided into two groups: study group (n=85, PCOS women) and control group (n=86 normal women). The blood sample was obtained on the 3<sup>rd</sup> day of menstruation cycle. IL-17, IL-1&#x003b1;, IL-1&#x003b2;, and TNF-&#x003b1; concentrations were determined in both groups.</p></sec><sec><title>Results:</title><p>The median serum level of IL-1&#x003b1; in the PCOS group was higher than the control group (293.3 and 8.0, respectively, p&#x0003c;0.001). Also, the median serum level of IL-1&#x003b2; was higher than the control group (5.9 and 3.1 respectively). But the median serum of level IL-17 in women with PCOS was significantly lower than the control group (p&#x0003c;0.001).</p></sec><sec><title>Conclusion:</title><p>Our results confirm that PCOS is a low-level chronic inflammation. </p></sec></abstract><kwd-group><title>Key Words</title><kwd>Polycystic ovary syndrome</kwd><kwd>IL1&#x003b1;-1&#x003b2;</kwd><kwd>IL-17A</kwd><kwd>Sympathetic nervous system</kwd></kwd-group></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>Polycystic ovary syndrome (PCOS) is the most common female endocrine disorder. Chronic anovulation, hyperandrogenism and polycystic in ovaries are the most common endocrine disorder in women between the ages of 18 and 44 (<xref rid="B1" ref-type="bibr">1</xref>). PCOS is a cause of female infertility and its prevalence is 15-20% among infertile women (<xref rid="B2" ref-type="bibr">2</xref>). Studies have been shown that PCOS is a chronic low-level inflammation and this chronic disease can be a potential cause of the long-term consequence of PCOS (<xref rid="B3" ref-type="bibr">3</xref>, <xref rid="B4" ref-type="bibr">4</xref>). In vitro studies suggest that pro-inflammatory stimuli are capable of up-regulation of the steroidogenic enzymes for the production of androgens in theca cells of the ovary (hyperandrogenism) (<xref rid="B5" ref-type="bibr">5</xref>). ''This concept raises the possibility that inflammation may be capable of directly inducing hyperandrogenism in PCOS'' (<xref rid="B6" ref-type="bibr">6</xref>). </p><p>52-64% of PCOS women have android obesity that is independently associated with the metabolic abnormalities like insulin resistant (IR) (<xref rid="B7" ref-type="bibr">7</xref>). Rahmouni and colleagues in 2004 reported that the intracerebroventricular injection of insulin increases sympathetic activation via the arcuate nucleus (<xref rid="B8" ref-type="bibr">8</xref>). The metabolic abnormalities like IR have a strong link with chronic inflammation (<xref rid="B9" ref-type="bibr">9</xref>). </p><p>''Over the past decades, evidence has accumulated clearly demonstrating a pivotal role for the sympathetic nervous system and its neurotransmitters in regulating inflammation'' (<xref rid="B10" ref-type="bibr">10</xref>). In 1903 for the first time, the role of sympathetic nervous system in inflammation could be found in an article (<xref rid="B11" ref-type="bibr">11</xref>). Immunity barrier and immunoregulatory mechanisms are very important in the processes of follicle development, fertilization, and implantation of the fertilized egg in the uterus (<xref rid="B12" ref-type="bibr">12</xref>). The pro-inflammatory cytokines, particularly interleukin (IL)-1 activates the hypothalamous-pituotary-adrenal (HPA) axis (<xref rid="B13" ref-type="bibr">13</xref>). HPA axis controls adrenal steroidogenesis and metabolic factors including insulin and obesity-related signals (<xref rid="B14" ref-type="bibr">14</xref>). </p><p>''IL-1 is a multifunctional cytokine and it has highly inflammatory features in reproductive biology and is believed to affect the processes of fertilization and implantation'' (<xref rid="B15" ref-type="bibr">15</xref>). Intra-cerebroventricular administration of IL-1 stimulates the production of Lutein hormone (LH) and follicle-stimulating hormone (<xref rid="B1" ref-type="bibr">1</xref>) from the gonadotropes (<xref rid="B16" ref-type="bibr">16</xref>). Interleukin-1 alpha and beta directly affect progesterone and oestradiol production in cultures of purified human granulosa cells (<xref rid="B17" ref-type="bibr">17</xref>). IL-1 alpha directly inhibites the production of oestradiol by human ovarian granulosa cells (<xref rid="B18" ref-type="bibr">18</xref>). IL-1&#x003b2; stimulates basal progesterone secretion in the human granulosa and theca cells and in small and large follicles in vitro (<xref rid="B19" ref-type="bibr">19</xref>). IL-1&#x003b2; in cumulus and granulosic cells of equine increases the level of PGF2-a and progesterone, which suggests that IL-1 can be involved in equine oocyte invitro maturation. (<xref rid="B20" ref-type="bibr">20</xref>). Gonadotropins can stimulate IL-1&#x003b2; and then it inhibits both LH and Human chorionic gonadotropin (LH/hCG) and FSH-stimulated progesterone and estradiol secretion by the follicular theca and granulosa cells, affecting cAMP production, that suggests a follicle-stage dependent regulatory role of IL-1 on ovarian follicles (<xref rid="B21" ref-type="bibr">21</xref>). Chen and coworkers demonstrated that the human granulosa-luteal cells express IL-1&#x003b2; transcript, and LH can stimulate this transcription in a dose-dependent manner. On the contrary, IL-1&#x003b2; significantly decreased LH-dependent estradiol production in these cells. ''These results suggest that LH may exert its action on the steroidogenesis of granulosa cell through, at least in part, the activation of the IL-1&#x003b2; gene'' (<xref rid="B22" ref-type="bibr">22</xref>). In the brain, interleukin-1&#x003b2; can reduce the release of monoamines: serotonin (5-HT), dopamine and noradrenaline. The role of IL-1&#x003b2; in the monoamine metabolism in the basal ganglia can help for plasticity of anxiety and depression in the brain (<xref rid="B23" ref-type="bibr">23</xref>).</p><p>17A is a prototypic member of the interleukin-17 (IL-17) cytokines. In this family, IL-17A, IL-17F, and IL-17E have known better. Two studies show that the role of these proteins in adaptive and innate immunity (<xref rid="B24" ref-type="bibr">24</xref>, <xref rid="B25" ref-type="bibr">25</xref>). Experimental studies show that IL-17A has a novel potential role in the neuroanatomical plasticity of sympathetic autonome system SAS that can accompany inflammation (<xref rid="B26" ref-type="bibr">26</xref>, <xref rid="B27" ref-type="bibr">27</xref>). </p><p>The aim of this study was the investigation of the relationship between cytokines' (IL1&#x003b1;-1&#x003b2;, 17A, and tumor necrosis factor (TNF) pattern and SAS in women with PCOs. In the last few decades, PCOS is known as a chronic low-level inflammatory disease, so we need to know the pattern of these changes.</p></sec><sec sec-type="materials|methods"><title>Materials and methods</title><p>
<bold>Participants</bold>
</p><p>In this case-control study, 171 women were participated in two groups: 85 PCOS women (study group) and 86 healthy women (control group: male factor). is All women with PCOS visited at Vali-e-Asr infertility clinic affiliated to Tehran University of Medical Sciences from February 2012 to April 2013.. The European Society of Human Reproduction and Embryology and the American Society for Reproductive Medicine (ESHRE/ASRM) criteria were considered for diagnostic of women with PCOS (<xref rid="B28" ref-type="bibr">28</xref>). </p><p>All of the participantsaged 20-40 yr without another chronic disease, for example,, immune system, cardiovascular, thyroid, diabetes and any medication. The body mass index (BMI) was under 28 and they have irregular menstrual cycle that is common in women with PCO. 5 ml venous blood sample was obtained from all participants on the third day of menstruation cycle. Serum samples for all patients were obtained by centrifugation at 3000 rpm for 10 min, then stored at -80<sup>o</sup>C until analysis. </p><p>
<bold>Questionnaire</bold>
</p><p>A demographic questionnaire was filled for all participants. Clinical and anthropometric variables, including BMI, hirsutism and duration of infertility were recorded.</p><p>
<bold>Biochemical study</bold>
</p><p>The concentration of serum levels of IL-1&#x003b1;, IL-1&#x003b2;, IL-17 and tumor necrosis factor (TNF&#x003b1;) (ELISA kit, Monobind from Austria) were measured.</p><p>
<bold>Ethical consideration</bold>
</p><p>. Informed consent was obtained from all women. This study was approved in ethical committee of Tehran University of Medical Sciences as date and number: IR.TUMS.VCR.REC.1395.1329.</p><p>
<bold>Statistical analysis</bold>
</p><p>The mean and standard deviation was used for the quantitative variables and t test was applied for comparing between the study groups. The qualitative variables were presented with count and percentage and chi-square test was used for comparing between the study groups. According to departure from a normal distribution and for presenting inflammatory cytokines, the median was used. Mann-Whitney U test was used for variables between two study groups. The multinomial linear regression model was used to delet the confounding effect. The data were analyzed in IBM Statistical Package for the Social Sciences, version 19.0, SPSS Inc, Chicago, Illinois, USA (SPSS). P value less than 0.05 considered as the significant level. </p></sec><sec sec-type="results"><title>Results</title><p>Weight and BMI were more in the PCOS group than the control group (p&#x0003c;0.001) Regarding the duration of marriage and infertility,parity and gravidity, there was no significant difference between two groups (<xref ref-type="table" rid="T1">Table I</xref>). But the occupation rate in the PCOS group was higher than the controls (p=0.002). The symptom of PCO was significantly higher in the PCO women. Serum level of IL-17&#x003b1; in the PCOS group was significantly lower than the control group (p&#x0003c;0.001). Both IL-1&#x003b1; (p&#x0003c;0.001) and IL-1&#x003b2; (p=0.017) were significantly higher in the PCOS than the control group (<xref ref-type="table" rid="T2">Table II</xref>). </p><p>A multinomial linear regression model was used to clarify the relationship between PCOS and IL17 (<xref ref-type="table" rid="T3">Table III</xref>). Age (&#x003b2;=-3.3, SE&#x003b2;=1.4, p=0.020) and having PCOS (&#x003b2;=-58.8, SE&#x003b2;=16.8, p=0.001) were significantly related with IL-17&#x003b1; (R2=0.139). In <xref ref-type="fig" rid="F1">Figure 1</xref>, (Chart 1 was changed as <xref ref-type="fig" rid="F1">figure 1</xref>), we showed that IL17&#x003b1; in the serum of women with PCO is lower than the control group.</p><table-wrap id="T1" position="float"><label>Table I</label><caption><p>Comparison of demographic data between the study and control groups</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="justify" valign="middle" colspan="2" rowspan="1">
<bold>Variables</bold>
</th><th align="center" valign="middle" rowspan="1" colspan="1">
<bold>Control group (n = 86)</bold>
</th><th align="center" valign="middle" rowspan="1" colspan="1">
<bold>PCOS group (n = 85)</bold>
</th><th align="center" valign="middle" rowspan="1" colspan="1">
<bold>p-value</bold>
</th></tr></thead><tbody><tr><td align="justify" valign="middle" colspan="2" rowspan="1">Age (2) <xref ref-type="table-fn" rid="TFN1">&#x02020;</xref></td><td align="center" valign="middle" rowspan="1" colspan="1">29.5 &#x000b1; 5.1</td><td align="center" valign="middle" rowspan="1" colspan="1">27.1 &#x000b1; 4.4</td><td align="center" valign="middle" rowspan="1" colspan="1">0.001</td></tr><tr><td align="justify" valign="middle" colspan="2" rowspan="1">Duration of marriage (2) <xref ref-type="table-fn" rid="TFN1">&#x02020;</xref></td><td align="center" valign="middle" rowspan="1" colspan="1">6.88 &#x000b1; 4.01</td><td align="center" valign="middle" rowspan="1" colspan="1">6.52 &#x000b1; 3.42</td><td align="center" valign="middle" rowspan="1" colspan="1">0.537</td></tr><tr><td align="justify" valign="middle" colspan="2" rowspan="1">Duration of infertility (2) <xref ref-type="table-fn" rid="TFN1">&#x02020;</xref></td><td align="center" valign="middle" rowspan="1" colspan="1">4.33 &#x000b1;3.96</td><td align="center" valign="middle" rowspan="1" colspan="1">4.84 &#x000b1; 3.22</td><td align="center" valign="middle" rowspan="1" colspan="1">0.365</td></tr><tr><td align="justify" valign="middle" colspan="2" rowspan="1">BMI (kg/m<sup>2</sup>) <xref ref-type="table-fn" rid="TFN1">&#x02020;</xref></td><td align="center" valign="middle" rowspan="1" colspan="1">25.41 &#x000b1; 3.76</td><td align="center" valign="middle" rowspan="1" colspan="1">27.39 &#x000b1; 3.94</td><td align="center" valign="middle" rowspan="1" colspan="1">0.001</td></tr><tr><td align="justify" valign="middle" colspan="2" rowspan="1">Gravidity (count) <xref ref-type="table-fn" rid="TFN1">&#x02020;</xref></td><td align="center" valign="middle" rowspan="1" colspan="1">0.40 &#x000b1; 0.69</td><td align="center" valign="middle" rowspan="1" colspan="1">0.41 &#x000b1; 0.75</td><td align="center" valign="middle" rowspan="1" colspan="1">0.863</td></tr><tr><td align="justify" valign="middle" colspan="2" rowspan="1">Years of education <xref ref-type="table-fn" rid="TFN2">&#x02021;</xref></td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="bottom" rowspan="1" colspan="1">0.864</td></tr><tr><td align="justify" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1">Less than 12 </td><td align="center" valign="middle" rowspan="1" colspan="1">27 (31.40%)</td><td align="center" valign="middle" rowspan="1" colspan="1">30 (35.29%)</td><td align="center" valign="bottom" rowspan="1" colspan="1"/></tr><tr><td align="justify" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1">12 (diploma)</td><td align="center" valign="middle" rowspan="1" colspan="1">46 (53.49%)</td><td align="center" valign="middle" rowspan="1" colspan="1">43 (50.59%)</td><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="justify" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1">More than 12 </td><td align="center" valign="middle" rowspan="1" colspan="1">13 (15.12%)</td><td align="center" valign="middle" rowspan="1" colspan="1">12 (14.12%)</td><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="justify" valign="middle" colspan="2" rowspan="1">Occupation <xref ref-type="table-fn" rid="TFN2">&#x02021;</xref></td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="bottom" rowspan="1" colspan="1">0.002</td></tr><tr><td align="justify" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1">Housewife</td><td align="center" valign="middle" rowspan="1" colspan="1"> 14 (16.28%)</td><td align="center" valign="middle" rowspan="1" colspan="1">2 (2.35%)</td><td align="center" valign="bottom" rowspan="1" colspan="1"/></tr><tr><td align="justify" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1">Occupied</td><td align="center" valign="middle" rowspan="1" colspan="1">72 (83.72%)</td><td align="center" valign="middle" rowspan="1" colspan="1">83 (97.65%)</td><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="justify" valign="middle" colspan="2" rowspan="1">menstrual state <xref ref-type="table-fn" rid="TFN2">&#x02021;</xref></td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="bottom" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="justify" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1">Regular</td><td align="center" valign="middle" rowspan="1" colspan="1">71 (82.56%)</td><td align="center" valign="middle" rowspan="1" colspan="1">27 (31.76%)</td><td align="center" valign="bottom" rowspan="1" colspan="1"/></tr><tr><td align="justify" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1">Irregular</td><td align="center" valign="middle" rowspan="1" colspan="1">15 (17.44%)</td><td align="center" valign="middle" rowspan="1" colspan="1">58 (68.24%)</td><td align="center" valign="middle" rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><p>BMI: body mass index</p><fn id="TFN1"><label>&#x02020;</label><p>: Data are presented as mean &#x000b1; standard deviation, using independent t- test </p></fn><fn id="TFN2"><label>&#x02021;</label><p>: Data are presented as count (percentage), using chi-square test</p></fn></table-wrap-foot></table-wrap><table-wrap id="T2" position="float"><label>Table II</label><caption><p>Comparison of inflammatory cytokines between study and control groups</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="middle" rowspan="2" colspan="1">
<bold>Interleukin variation</bold>
</th><th align="center" valign="middle" colspan="2" rowspan="1">
<bold>PCOS group (n = 85)</bold>
<hr/>
</th><th align="center" valign="middle" colspan="2" rowspan="1">
<bold>Control group (n = 86)</bold>
<hr/>
</th><th align="center" valign="middle" rowspan="2" colspan="1">
<bold>P-value (Mann-Whitney)</bold>
</th></tr><tr><th align="center" valign="middle" rowspan="1" colspan="1">
<bold>mean</bold>
</th><th align="center" valign="middle" rowspan="1" colspan="1">
<bold>SD</bold>
</th><th align="center" valign="middle" rowspan="1" colspan="1">
<bold>mean</bold>
</th><th align="center" valign="middle" rowspan="1" colspan="1">
<bold>SD</bold>
</th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">IL-1-&#x003b1; (pg/ml)</td><td align="center" valign="middle" rowspan="1" colspan="1">401.40</td><td align="center" valign="middle" rowspan="1" colspan="1">228.61</td><td align="center" valign="middle" rowspan="1" colspan="1">19.32</td><td align="center" valign="middle" rowspan="1" colspan="1">37.89</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>&#x0003c;0.001</bold>
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">IL1-&#x003b2; (pg/ml)</td><td align="center" valign="middle" rowspan="1" colspan="1">17.38</td><td align="center" valign="middle" rowspan="1" colspan="1">40.56</td><td align="center" valign="middle" rowspan="1" colspan="1">11.55</td><td align="center" valign="middle" rowspan="1" colspan="1">23.65</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>0.017</bold>
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">IL-17 (pg/ml)</td><td align="center" valign="middle" rowspan="1" colspan="1">5.80</td><td align="center" valign="middle" rowspan="1" colspan="1">6.90</td><td align="center" valign="middle" rowspan="1" colspan="1">59.92</td><td align="center" valign="middle" rowspan="1" colspan="1">121.11</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>&#x0003c;0.001</bold>
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">TNF-&#x003b1; (pg/ml)</td><td align="center" valign="middle" rowspan="1" colspan="1">10.91</td><td align="center" valign="middle" rowspan="1" colspan="1">26.42</td><td align="center" valign="middle" rowspan="1" colspan="1">45.60</td><td align="center" valign="middle" rowspan="1" colspan="1">172.48</td><td align="center" valign="middle" rowspan="1" colspan="1">0.119</td></tr></tbody></table><table-wrap-foot><p>SD: standard deviation. </p><p>IL-1-&#x003b1;; </p><p>IL1-&#x003b2; ;</p><p>IL-17 : </p><p>TNF-&#x003b1;:</p></table-wrap-foot></table-wrap><table-wrap id="T3" position="float"><label>Table III</label><caption><p>Regression model of IL17 (Regression model R<sup>2</sup> = 0.139</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="middle" rowspan="2" colspan="1"/><th align="center" valign="middle" colspan="2" rowspan="1">
<bold>Unstandardized Coefficients</bold>
<hr/>
</th><th align="center" valign="middle" rowspan="2" colspan="1">
<bold>Standardized Coefficients</bold>
</th><th align="center" valign="middle" rowspan="2" colspan="1">
<bold>t</bold>
</th><th align="center" valign="middle" rowspan="2" colspan="1">
<bold>p-value</bold>
</th></tr><tr><th align="center" valign="middle" rowspan="1" colspan="1">
<bold>B</bold>
</th><th align="center" valign="middle" rowspan="1" colspan="1">
<bold>Std. Error</bold>
</th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">Model constant</td><td align="center" valign="middle" rowspan="1" colspan="1">133.121 </td><td align="center" valign="middle" rowspan="1" colspan="1"> 76.970</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">1.730 </td><td align="center" valign="middle" rowspan="1" colspan="1"> 0.086</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">BMI (kg/m<sup>2</sup>)</td><td align="center" valign="middle" rowspan="1" colspan="1"> 1.316</td><td align="center" valign="middle" rowspan="1" colspan="1">1.782 </td><td align="center" valign="middle" rowspan="1" colspan="1">0.060 </td><td align="center" valign="middle" rowspan="1" colspan="1">0.738 </td><td align="center" valign="middle" rowspan="1" colspan="1">0.462 </td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Age (years)</td><td align="center" valign="middle" rowspan="1" colspan="1">-3.316 </td><td align="center" valign="middle" rowspan="1" colspan="1">1.413 </td><td align="center" valign="middle" rowspan="1" colspan="1">-0.190 </td><td align="center" valign="middle" rowspan="1" colspan="1">-2.347 </td><td align="center" valign="middle" rowspan="1" colspan="1">0.020 </td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Occupation</td><td align="center" valign="middle" rowspan="1" colspan="1">-31.410 </td><td align="center" valign="middle" rowspan="1" colspan="1">23.652 </td><td align="center" valign="middle" rowspan="1" colspan="1">-0.106 </td><td align="center" valign="middle" rowspan="1" colspan="1">-1.328 </td><td align="center" valign="middle" rowspan="1" colspan="1">0.186 </td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Irregular menstrual</td><td align="center" valign="middle" rowspan="1" colspan="1">-9.421</td><td align="center" valign="middle" rowspan="1" colspan="1">15.990</td><td align="center" valign="middle" rowspan="1" colspan="1">-0.054</td><td align="center" valign="middle" rowspan="1" colspan="1">-0.589</td><td align="center" valign="middle" rowspan="1" colspan="1">0.557</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">PCOS</td><td align="center" valign="middle" rowspan="1" colspan="1">-58.817</td><td align="center" valign="middle" rowspan="1" colspan="1">16.801</td><td align="center" valign="middle" rowspan="1" colspan="1">-0.341</td><td align="center" valign="middle" rowspan="1" colspan="1">-3.501</td><td align="center" valign="middle" rowspan="1" colspan="1">0.001</td></tr></tbody></table><table-wrap-foot><p>Age (P = 0.020) and PCO (P = 0.001) were significantly related with IL-17&#x000a0;.</p><p>BMI: body mass index </p><p>PCOS: Polycystic ovary syndrome</p><p>B: Regression coefficientsStd. Error: Standard Error</p></table-wrap-foot></table-wrap><fig id="F1" position="float"><label>Figure 1</label><caption><p>Comparison of mean and standard error (According to high departure from the normal distribution, SD makes the error bar very long, so SE has been used) of IL-17 between the control and PCOS groups. IL-17 in the PCO group was significantly lower than the controls. Point present median</p></caption><graphic xlink:href="ijrb-15-375-g001"/></fig></sec><sec sec-type="discussion"><title>Discussion</title><p>This study confirms that the PCOS is an inflammatory syndrome. The potential mutual interaction between two super systems (SAS and Immunity) can be the cause of increasing of serum levels of IL-1 in PCOS women. There are two issues for discussion of this study in central and peripheral areas: 1) Two axes, SAS and HPA axis in central as a neuroendocrine aspect that has a main pathologic background in PCOS, 2) the reflection effect of a neuro-immune-endocrine aspect of the ovary in PCOS.</p><p>Women with PCOS have significantly higher HPA axis and sympathetic nerve activity than their matched controls. The increased sympathetic outflow can be related to the hormonal and metabolic features that may be relevant to the pathophysiology of this syndrome (<xref rid="B29" ref-type="bibr">29</xref>). The pro-inflammatory cytokines, particularly interleukin-1 can activate HPA axis (<xref rid="B30" ref-type="bibr">30</xref>). Smagin and colleagues in 1996 showed that activation of the HPA axis is due to the noradrenergic terminals in the hypothalamus that play an important role in the IL-l induced (<xref rid="B31" ref-type="bibr">31</xref>). On the other hand, the noradrenergic innervation of hypothalamus can participate in the adrenocortical responses to the interleukin-1. Accordingly, of this response, noradrenaline (NA) increases the corticosterone-induced IL (<xref rid="B32" ref-type="bibr">32</xref>). ''IL-1 has been shown to up-regulate glucocorticoid receptor (GR mRNA expression in hypothalamic corticotrophin-releasing hormone (CRH) secreting cells'' (<xref rid="B33" ref-type="bibr">33</xref>). </p><p>In women with PCO, cortisol level does not have significant changes (<xref rid="B34" ref-type="bibr">34</xref>). The up-regulation of GR can be the reason of normal rate of cortisol in women with PCO. These findings confirm Turnbul&#x0006c;&#x00315;s report that the noradrenergic innervation of hypothalamus participates in responses of adrenocortical system to IL1. They suggest that ''this neuro-immune-endocrine action of cytokines is mediated primarily at the level of the central nervous system (CNS)'' (<xref rid="B13" ref-type="bibr">13</xref>). </p><p>In CNS, some nuclei of the supraspinal brain, such as collection of nuclei in the hypothalamus, locus coeruleus (LC) and amygdala which are Trans neuronal connected with the ovary. All these nuclei are involved in the physiologic function of the ovaries. LC is the major noradrenaline NA nucleus in the brain. LC located adjacent to the IV ventricle in the pontine brainstem. Anselmo-Franci and coworkers, in 1997 showed that the electrolytic lesions of the LC can block the pre-ovulatory surge of LH in the ovary of the rat. The reduction of NA in the medial basal hypothalamus (<xref rid="B3" ref-type="bibr">3</xref>) is the main factor for blockade of LH surge (<xref rid="B35" ref-type="bibr">35</xref>). Because the positive feedback action of estradiol (E<sub>2</sub>) on LH secretion is the most important role of LC in central function of the reproductive system (<xref rid="B36" ref-type="bibr">36</xref>). Our previous study showed that LC lesion could augment the estradiol concentration in PCO rats. This finding suggests that blocking the release of NA by LC lesion in rats with PCO can increase the serum concentrations of estradiol (<xref rid="B37" ref-type="bibr">37</xref>). </p><p>Raphael <italic>et al</italic> also in 2013, reported that the stimulatory effect of NA on the release of gonadotropin-releasing hormone occurs during the positive feedback of ovarian steroids (<xref rid="B38" ref-type="bibr">38</xref>). Estrogen up-regulates NA release in the Medio basal hypothalamus. Increased levels of estrogen from the ovaries can be the primary cause of the Gonadotropin releasing hormone surge for triggering of Luteinizing hormone surge (<xref rid="B39" ref-type="bibr">39</xref>). </p><p>This positive correlation between serum estradiol levels and NA, in patients with PCOS, can be the main executive factor at the brain-ovary axis. All of these findings confirm the main role of SAS (NA) on ovary function and dysregulation of it on the brain-ovary axis in PCOS.</p><p>Inflammation is not only an acute response to trauma or infection, but it is also a response to the ongoing processes of cell turnover associated with aging. In this regard, the inflammatory response regulates fundamental processes intrinsic to cellular homeostasis, including proliferation, necrosis, and apoptosis (<xref rid="B40" ref-type="bibr">40</xref>). ''The progression of apoptosis in follicular cells is dependent on the cooperative regulation of different paracrine and autocrine factors; it is likely that none of these factors are specifically required in the control of follicle growth or death'' (<xref rid="B41" ref-type="bibr">41</xref>). One of the extrinsic factors as initiating mechanisms of apoptosis in follicle atresia process is cytokines (<xref rid="B42" ref-type="bibr">42</xref>). The present study demonstrates that the crosstalk between these two super systems, SAS and immune system in women with PCOS. The inflammation amplifier is activated by NA and the stimulation of cytokines, such as TNF-&#x003b1;, IL-17 in the subsequent expression of various target genes for chemokines (<xref rid="B43" ref-type="bibr">43</xref>). </p><p>Petit and colleagues reported that ''the enhanced whole body glucose metabolism seen after central administration of IL-1&#x003b1; is mediated by increased sympathoadrenal activity. They suggested that the IL-1&#x003b1; induced increase in pancreatic insulin and glucagon secretion, as well as part of the peripheral catecholamine release,, is mediated by central adrenoreceptors'' (<xref rid="B44" ref-type="bibr">44</xref>). In the other hand, the administration of systemic and intracerebral IL1 can increase the turnover of NA in hippocampus and hypothalamus in the brain (<xref rid="B45" ref-type="bibr">45</xref>). McNamee and coworkers, in 2010 suggested that NA has neuroprotective properties because negatively regulates the IL-1 system. This neuro-inflammation is characterized by &#x003b2;-adrenoceptor (<xref rid="B46" ref-type="bibr">46</xref>). These findings confirm the important role of SAS in the neuro-immune aspect of PCOS. So, the over activity of SAS can never play the normal negative regulatory role for reduction of IL1 in women with PCOS. PCOS is a chronic condition and recent studies show that PCOS as chronic low-grade subclinical inflammation which has been increasingly recognized as an interposer in the endocrine, metabolic and reproductive disturbances. </p><p>In this study, the inflammatory nature of PCOS (low-grade chronic) was confirmed as similar reports over the past decade (<xref rid="B47" ref-type="bibr">47</xref>). ''Sympatho-adrenergic pathways in the innate immune system may represent novel anti-inflammatory and immune-modulating targets with significant therapeutic potential'' (<xref rid="B48" ref-type="bibr">48</xref>). The crosstalk between two super systems is clear but in PCOS women the role of NA in mediating inflammatory responses is less clear, with evidence of both pro- and anti-inflammatory effects. </p><p>In this study, we suggest that in women with PCOS: 1) Increased IL-1&#x003b1; can impair the feedback system of NA (neuro-inflammation process) or vice versa. these data confirm Luotol&#x00061;&#x00315;s study in 2016 that explained an increased IL-1Ra level in women with PCOS (<xref rid="B49" ref-type="bibr">49</xref>). 2) Increased IL-1&#x003b2; could be due to the lack of ovulation (anovulation) in women with PCOS (<xref rid="B50" ref-type="bibr">50</xref>). 3) Regulation of IL-17A by adrenal hormones caused a significant reduction of this cytokine in the serum of PCOS women that confirms the result of experimental study of Bosmann and coworkers, in 2013 (<xref rid="B51" ref-type="bibr">51</xref>). ''IL-17 can act on sympathetic somata and distal neurites to enhance neurite outgrowth and identify a novel potential role for IL-17 in the neuroanatomical plasticity that accompanies inflammation'' (<xref rid="B52" ref-type="bibr">52</xref>). 4) This impaired cytokine pattern possibly can play a major role in the immunopathogenesis of PCOS. 5) The investigation of the neuro-immune axis can be an effective study in identifying the etiology of PCOS.</p></sec><sec sec-type="conclusions"><title>Conclusion</title><p>This study confirms that the PCOS is an inflammation disease with an abnormal lymphocyte subset hat possibly associated with a dysfunction in the neuro-immune axis. </p></sec></body><back><ack><title>Acknowledgments</title><p>The Research Council of Tehran University of Medical Sciences, Tehran, Iran supported this study by a grant publication No. 39-19492, revised 2012.</p></ack><sec sec-type="COI-statement"><title>Conflict of interest</title><p>None.</p></sec><ref-list><title>References</title><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Norman</surname><given-names>RJ</given-names></name><name><surname>Dewailly</surname><given-names>D</given-names></name><name><surname>Legro</surname><given-names>RS</given-names></name></person-group><article-title>Polycystic ovary syndrome</article-title><source> Lancet</source><year>2007</year><volume>370</volume><fpage>685</fpage><lpage>697</lpage><pub-id pub-id-type="pmid">17720020</pub-id></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Badawy</surname><given-names>A</given-names></name><name><surname>Elnashar</surname><given-names>A</given-names></name></person-group><article-title>Treatment options for polycystic ovary syndrome</article-title><source> Int J Womens Health</source><year>2011</year><volume>3</volume><fpage>25</fpage><lpage>35</lpage><pub-id pub-id-type="pmid">21339935</pub-id></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Repaci</surname><given-names>A</given-names></name><name><surname>Gambineri</surname><given-names>A</given-names></name><name><surname>Pasquali</surname><given-names>R</given-names></name></person-group><article-title>The role of low-grade inflammation in the polycystic ovary syndrome</article-title><source> Mol Cell Endocrinol</source><year>2011</year><volume>335</volume><fpage>30</fpage><lpage>41</lpage><pub-id pub-id-type="pmid">20708064</pub-id></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fernandez-Real</surname><given-names>JM</given-names></name><name><surname>Ricart</surname><given-names>W</given-names></name></person-group><article-title>Insulin resistance and chronic cardiovascular inflammatory syndrome</article-title><source> Endocr Rev</source><year>2003</year><volume>24</volume><fpage>278</fpage><lpage>301</lpage><pub-id pub-id-type="pmid">12788800</pub-id></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shorakae</surname><given-names>S</given-names></name><name><surname>Teede</surname><given-names>H</given-names></name><name><surname>de</surname><given-names>Courten B</given-names></name><name><surname>Lambert</surname><given-names>G</given-names></name><name><surname>Boyle</surname><given-names>J</given-names></name><name><surname>Moran</surname><given-names>LJ</given-names></name></person-group><article-title>The emerging role of chronic low-grade inflammation in the pathophysiology of polycystic ovary syndrome</article-title><source> Semin Reprod Med</source><year>2015</year><volume>33</volume><fpage>257</fpage><lpage>269</lpage><pub-id pub-id-type="pmid">26132930</pub-id></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frank</surname><given-names>Gonz&#x000e1;lez</given-names></name></person-group><article-title>Inflammation in Polycystic Ovary Syndrome: Underpinning of insulin resistance and ovarian dysfunction</article-title><source> Steroids</source><year>2012</year><volume>77</volume><fpage>300</fpage><lpage>305</lpage><pub-id pub-id-type="pmid">22178787</pub-id></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goodarzi</surname><given-names>MO</given-names></name><name><surname>Korenman</surname><given-names>SG</given-names></name></person-group><article-title>The importance of insulin resistance in polycystic ovary syndrome</article-title><source> Fertil Steril</source><year>2003</year><volume>80</volume><fpage>255</fpage><lpage>258</lpage><pub-id pub-id-type="pmid">12909480</pub-id></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rahmouni</surname><given-names>K</given-names></name><name><surname>Morgan</surname><given-names>DA</given-names></name><name><surname>Morgan</surname><given-names>GM</given-names></name></person-group><article-title>Hypothalamic PI3K and MAPK differentially mediate regional sympathetic activation to insulin</article-title><source> J Clin Invest</source><year>2004</year><volume>114</volume><fpage>652</fpage><lpage>658</lpage><pub-id pub-id-type="pmid">15343383</pub-id></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flaa</surname><given-names>A</given-names></name><name><surname>Aksnes</surname><given-names>TA</given-names></name><name><surname>Kjeldsen</surname><given-names>SE</given-names></name></person-group><article-title>Increased sympathetic reactivity may predict insulin resistance: an 18-year follow-up study</article-title><source> Metabolism</source><year>2008</year><volume>57</volume><fpage>1422</fpage><lpage>1427</lpage><pub-id pub-id-type="pmid">18803948</pub-id></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pongratz</surname><given-names>G</given-names></name><name><surname>Straub</surname><given-names>RH</given-names></name></person-group><article-title>The Sympathetic Nervous Response in Inflammation</article-title><source> Arthritis Res Ther</source><year>2014</year><volume>16</volume><fpage>504</fpage><pub-id pub-id-type="pmid">25789375</pub-id></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meltzer</surname><given-names>SJ</given-names></name><name><surname>Meltzer</surname><given-names>C</given-names></name></person-group><article-title>On a difference in the influence upon inflammation between the section of the sympathetic nerve and the removal of the sympathetic ganglion</article-title><source> J Med Res</source><year>1903</year><volume>10</volume><fpage>135</fpage><lpage>141</lpage><pub-id pub-id-type="pmid">19971556</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zalcman</surname><given-names>S</given-names></name><name><surname>Green-Johnson</surname><given-names>JM</given-names></name><name><surname>Murray</surname><given-names>L</given-names></name><name><surname>Nance</surname><given-names>DM</given-names></name><name><surname>Dyck</surname><given-names>D</given-names></name><name><surname>Anisman</surname><given-names>H</given-names></name><etal/></person-group><article-title>Cytokine-specific central monoamine alterations induced by interleukin-1, -2 and -6</article-title><source> Brain Res</source><year>1994</year><volume>643</volume><fpage>40</fpage><lpage>49</lpage><pub-id pub-id-type="pmid">7518332</pub-id></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turnbull</surname><given-names>AV</given-names></name><name><surname>Rivier</surname><given-names>CL</given-names></name></person-group><article-title>Regulation of the hypothalamic-pituitary-adrenal axis by cytokines: actions and mechanisms of action</article-title><source> Physiol Rev</source><year>1999</year><volume>79</volume><fpage>1</fpage><lpage>71</lpage><pub-id pub-id-type="pmid">9922367</pub-id></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lansdown</surname><given-names>A</given-names></name><name><surname>Rees</surname><given-names>DA</given-names></name></person-group><article-title>The sympathetic nervous system in polycystic ovary syndrome: a novel therapeutic target?</article-title><source> Clin Endocrinol (Oxf)</source><year>2012</year><volume>77</volume><fpage>791</fpage><lpage>801</lpage><pub-id pub-id-type="pmid">22882204</pub-id></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Escobar-Morreale</surname><given-names>HF</given-names></name><name><surname>Luque-Ramirez</surname><given-names>M</given-names></name><name><surname>San</surname><given-names>Millan JL</given-names></name></person-group><article-title>The molecular-genetic basis of functional hyperandrogenism and the polycystic ovary syndrome</article-title><source> Endocr Rev</source><year>2005</year><volume>26</volume><fpage>251</fpage><lpage>282</lpage><pub-id pub-id-type="pmid">15561799</pub-id></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sukhikh</surname><given-names>GT</given-names></name><name><surname>Vanko</surname><given-names>LV</given-names></name></person-group><article-title>Interrelationships between immune and reproductive systems in human</article-title><source> Russ JImmunol</source><year>1999</year><volume>4</volume><fpage>312</fpage><lpage>314</lpage><pub-id pub-id-type="pmid">12687144</pub-id></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xiao</surname><given-names>E</given-names></name><name><surname>Xia-Zhang</surname><given-names>L</given-names></name><name><surname>Thornell</surname><given-names>D</given-names></name><name><surname>Ferin</surname><given-names>M</given-names></name></person-group><article-title>Interleukin-1 stimulates luteinizing hormone release during the midfollicular phase in the rhesus monkey: A novel way in which stress may influence the menstrual cycle</article-title><source> J Clin Endocrinol Metab</source><year>1996</year><volume>81</volume><fpage>2136</fpage><lpage>2141</lpage><pub-id pub-id-type="pmid">8964841</pub-id></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Best</surname><given-names>CL</given-names></name><name><surname>Hill</surname><given-names>JA</given-names></name></person-group><article-title>Interleukin-1 alpha and-beta modulation of luteinized human granulosa cell oestrogen and progesterone biosynthesis</article-title><source> Hum Reprod</source><year>1995</year><volume>10</volume><fpage>3206</fpage><lpage>3210</lpage><pub-id pub-id-type="pmid">8822445</pub-id></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baratta</surname><given-names>M</given-names></name><name><surname>Basini</surname><given-names>G</given-names></name><name><surname>Bussolati</surname><given-names>S</given-names></name></person-group><article-title>Effects of interleukin-1 beta fragment (163-171) on progesterone and estradiol-17 beta release by bovine granulosa cells from different size follicles</article-title><source> Regul Pept</source><year>1996</year><volume>67</volume><fpage>187</fpage><lpage>194</lpage><pub-id pub-id-type="pmid">8988519</pub-id></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Caillaud</surname><given-names>M</given-names></name><name><surname>Gerard</surname><given-names>N</given-names></name></person-group><article-title>In vivo and In vitro effects of interleukin-1beta on equine oocyte maturation and on steroidogenesis and prostaglandin synthesis in granulosa and cumulus cells</article-title><source> Reprod Fertil Dev</source><year>2009</year><volume>21</volume><fpage>265</fpage><lpage>273</lpage><pub-id pub-id-type="pmid">19210917</pub-id></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kolbus</surname><given-names>A</given-names></name><name><surname>Walch</surname><given-names>K</given-names></name><name><surname>Nagele</surname><given-names>F</given-names></name></person-group><article-title>Interleukin-1 alpha but not interleukin-1 beta gene polymorphism is associated with polycystic ovary syndrome</article-title><source> J Reprod Immunol</source><year>2007</year><volume>73</volume><fpage>188</fpage><lpage>193</lpage><pub-id pub-id-type="pmid">16965825</pub-id></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>HF</given-names></name><name><surname>Shew</surname><given-names>JY</given-names></name><name><surname>Chao</surname><given-names>KH</given-names></name><name><surname>Chang</surname><given-names>LJ</given-names></name><name><surname>Ho</surname><given-names>HN</given-names></name><name><surname>Yang</surname><given-names>YS</given-names></name></person-group><article-title>Luteinizing hormone up-regulates the expression of interleukin-1 beta mRNA in human granulosa-luteal cells</article-title><source> Am J Reprod Immunol</source><year>2000</year><volume>43</volume><fpage>125</fpage><lpage>133</lpage><pub-id pub-id-type="pmid">10735588</pub-id></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kohen</surname><given-names>P</given-names></name><name><surname>Castro</surname><given-names>A</given-names></name><name><surname>Caballero-Campo</surname><given-names>P</given-names></name></person-group><article-title>Interleukin-1beta (IL-1beta) is a modulator of human luteal cell steroidogenesis: Localization of the IL type I system in the corpus luteum</article-title><source> J Clin Endocrinol Metab</source><year>1999</year><volume>84</volume><fpage>4239</fpage><lpage>4245</lpage><pub-id pub-id-type="pmid">10566679</pub-id></element-citation></ref><ref id="B24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pappu</surname><given-names>R</given-names></name><name><surname>Ramirez-Carrozzi</surname><given-names>V</given-names></name><name><surname>Sambandam</surname><given-names>A</given-names></name></person-group><article-title>The interleukin-17 cytokine family: critical players in host defence and inflammatory diseases</article-title><source> Immunology</source><year>2011</year><volume>134</volume><fpage>8</fpage><lpage>16</lpage><pub-id pub-id-type="pmid">21726218</pub-id></element-citation></ref><ref id="B25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jin</surname><given-names>W</given-names></name><name><surname>Dong</surname><given-names>C</given-names></name></person-group><article-title>IL-17 cytokines in immunity and inflammation</article-title><source> Emerg Microb Infect</source><year>2013</year><volume>2</volume><fpage>e60</fpage></element-citation></ref><ref id="B26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Habash</surname><given-names>T</given-names></name><name><surname>Saleh</surname><given-names>A</given-names></name><name><surname>Roy</surname><given-names>Chowdhury SK</given-names></name><name><surname>Smith</surname><given-names>DR</given-names></name><name><surname>Fernyhough</surname><given-names>P</given-names></name></person-group><article-title>The proinflammatory cytokine, interleukin-17A, augments mitochondrial function and neurite outgrowth of cultured adult sensory neurons derived from normal and diabetic rats</article-title><source> Exp Neurol</source><year>2015</year><volume>273</volume><fpage>177</fpage><lpage>189</lpage><pub-id pub-id-type="pmid">26321687</pub-id></element-citation></ref><ref id="B27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reinert-Hartwall</surname><given-names>L</given-names></name><name><surname>Honkanen</surname><given-names>J</given-names></name><name><surname>Salo</surname><given-names>HM</given-names></name><name><surname>Nieminen</surname><given-names>JK</given-names></name><name><surname>Luopaj&#x000e4;rvi</surname><given-names>K</given-names></name><name><surname>H&#x000e4;rk&#x000f6;nen</surname><given-names>T</given-names></name><etal/></person-group><article-title>Tolerance in Humans of advanced b Cell Autoimmunity and Impaired Glucose Th1/Th17 Plasticity Is a Marker of Advanced b Cell Autoimmunity and Impaired Glucose Tolerance in Humans</article-title><source> J Immunol</source><year>2015</year><volume>26</volume><fpage>67</fpage><lpage>75</lpage></element-citation></ref><ref id="B28"><label>28</label><element-citation publication-type="journal"><collab>The Rotterdom ESHRE/Asrm-sponsored PCOS consensus workshop group</collab><article-title>Revised 2003 consensus on diagnostic criteria and long term health risks related to polycystic ovary syndrome (PCOS)</article-title><source> Hum Reprod</source><year>2004</year><volume>19</volume><fpage>41</fpage><lpage>47</lpage><pub-id pub-id-type="pmid">14688154</pub-id></element-citation></ref><ref id="B29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sverrisdottir</surname><given-names>YB</given-names></name><name><surname>Mogrent</surname><given-names>T</given-names></name><name><surname>Kataoka</surname><given-names>J</given-names></name><name><surname>Janson</surname><given-names>PO</given-names></name><name><surname>Stener-Victorin</surname><given-names>E</given-names></name></person-group><article-title>Is polycystic ovary syndrome associated with high sympathetic nerve activity and size at birth?</article-title><source> Am J Physiol Endocrinol Metab</source><year>2008</year><volume>294</volume><fpage>E576</fpage><lpage>E581</lpage><pub-id pub-id-type="pmid">18198350</pub-id></element-citation></ref><ref id="B30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Besedovsky</surname><given-names>HO</given-names></name><name><surname>Del</surname><given-names>Rey A</given-names></name><name><surname>Klusman</surname><given-names>I</given-names></name><name><surname>Furukawa</surname><given-names>H</given-names></name><name><surname>Monge</surname><given-names>Arditi G</given-names></name><name><surname>Kabiersch</surname><given-names>A</given-names></name></person-group><article-title>Cytokines as modulators of the hypothalamus-pituitary-adrenal axis</article-title><source> J Steroid Biochem Mol Biol</source><year>1999</year><volume>40</volume><fpage>613</fpage><lpage>618</lpage></element-citation></ref><ref id="B31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smagin</surname><given-names>GN</given-names></name><name><surname>Swiergiel</surname><given-names>AH</given-names></name><name><surname>Dunn</surname><given-names>A</given-names></name></person-group><article-title>Peripheral administration of interleukin-1 increases extracellular concentrations of norepinephrine in rat hypothalamus: comparison with plasma corticosterone</article-title><source> PsychoNeuroEndocrinol</source><year>1996</year><volume>21</volume><fpage>83</fpage><lpage>93</lpage></element-citation></ref><ref id="B32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chuluyan</surname><given-names>H</given-names></name></person-group><article-title>Saphier D, RohnW</article-title><source> Noradrenergic innervation of the hypothalamus participates in the adrenocortical responses to interleukin-1. Neuroendocrinol</source><year>1992</year><volume>56</volume><fpage>106</fpage><lpage>111</lpage></element-citation></ref><ref id="B33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Angeli</surname><given-names>A</given-names></name><name><surname>Masera</surname><given-names>RG</given-names></name><name><surname>Sartori</surname><given-names>ML</given-names></name></person-group><article-title>Modulation by cytokines of glucocorticoid action</article-title><source> Ann N Y Acad Sci</source><year>1999</year><volume>876</volume><fpage>210</fpage><lpage>220</lpage><pub-id pub-id-type="pmid">10415612</pub-id></element-citation></ref><ref id="B34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zangeneh</surname><given-names>FZ</given-names></name><name><surname>Naghizadeh</surname><given-names>MM</given-names></name><name><surname>Abdollahi</surname><given-names>A</given-names></name><name><surname>Bagheri</surname><given-names>M</given-names></name></person-group><article-title>Synchrony between ovarian function &#x00026; sleep in polycystic ovary syndrome patients</article-title><source> Open J Obstet Gynecol</source><year>2014</year><volume>4</volume><fpage>725</fpage><lpage>731</lpage></element-citation></ref><ref id="B35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anselmo-Franci</surname><given-names>JA</given-names></name><name><surname>Franci</surname><given-names>CR</given-names></name><name><surname>Krulich</surname><given-names>L</given-names></name><name><surname>Antunes-Rodrigues</surname><given-names>J</given-names></name><name><surname>McCann</surname><given-names>SM</given-names></name></person-group><article-title>Locus coeruleus lesions decrease norepinephrine input into the medial preoptic area and medial basal hypothalamus and block the LH, FSH and prolactin preovulatory surge</article-title><source> Brain Res</source><year>1997</year><volume>767</volume><fpage>289</fpage><lpage>296</lpage><pub-id pub-id-type="pmid">9367260</pub-id></element-citation></ref><ref id="B36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vega</surname><given-names>Helena CV</given-names></name><name><surname>Franci</surname><given-names>CR</given-names></name><name><surname>Anselmo-Franci</surname><given-names>JA</given-names></name></person-group><article-title>Luteinizing hormone and luteinizing hormone-releasing hormone secretion is under locus coeruleus control in female rats</article-title><source> Brain Res</source><year>2002</year><volume>955</volume><fpage>245</fpage><lpage>252</lpage><pub-id pub-id-type="pmid">12419543</pub-id></element-citation></ref><ref id="B37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zangeneh</surname><given-names>FZ</given-names></name><name><surname>Abdollahi</surname><given-names>A</given-names></name><name><surname>Aminee</surname><given-names>F</given-names></name><name><surname>Naghizadeh</surname><given-names>MM</given-names></name></person-group><article-title>Locus coeruleus lesions and PCOS: role of the central and peripheral sympathetic nervous system in the ovarian function of rat</article-title><source> Iran J Reprod Med</source><year>2012</year><volume>10</volume><fpage>113</fpage><lpage>120</lpage><pub-id pub-id-type="pmid">25242983</pub-id></element-citation></ref><ref id="B38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raphael</surname><given-names>E</given-names></name><name><surname>Szawka</surname><given-names/></name><name><surname>Maristela</surname><given-names>O</given-names></name><name><surname>Poletini</surname><given-names/></name><name><surname>Cristiane</surname><given-names>M</given-names></name><name><surname>Leite</surname><given-names/></name><name><surname>Marcelo</surname><given-names>P</given-names></name></person-group><article-title>Leonardo BD</article-title><source> Release of norepinephrine in the preoptic area activates antral-ventral periventricular nucleus neurons and stimulates the surge of luteinizing hormone. Endocrinology</source><year>2013</year><volume>154</volume><fpage>363</fpage><lpage>374</lpage><pub-id pub-id-type="pmid">23150494</pub-id></element-citation></ref><ref id="B39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuo</surname><given-names>J</given-names></name><name><surname>Micevych</surname><given-names>PJ</given-names></name></person-group><article-title>Neurosteroids, trigger of the LH surge</article-title><source> Steroid Biochem Mol Biol</source><year>2012</year><volume>131</volume><fpage>57</fpage><lpage>65</lpage></element-citation></ref><ref id="B40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sathyapalan</surname><given-names>T</given-names></name><name><surname>Atkin</surname><given-names>SL</given-names></name></person-group><article-title>Mediators of inflammation in polycystic ovary syndrome in relation to adiposity</article-title><source> Mediat Inflammat</source><year>2010</year><volume>2010</volume><fpage>1</fpage><lpage>5</lpage></element-citation></ref><ref id="B41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hussein</surname><given-names>MR</given-names></name></person-group><article-title>Apoptosis in the ovary: molecular mechanisms</article-title><source>Hum Reprod Update </source><year>2005</year><volume>11</volume><fpage>162</fpage><lpage>177</lpage><pub-id pub-id-type="pmid">15705959</pub-id></element-citation></ref><ref id="B42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hennebold</surname><given-names>JD</given-names></name></person-group><article-title>Preventing Granulosa Cell Apoptosis Through the Action of a Single MicroRNA1</article-title><source> BiolI Reprod</source><year>2010</year><volume>83</volume><fpage>165</fpage><lpage>167</lpage></element-citation></ref><ref id="B43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Atsumi</surname><given-names>T</given-names></name><name><surname>Singh</surname><given-names>R</given-names></name><name><surname>Sabharwal</surname><given-names>L</given-names></name></person-group><article-title>Inflammation amplifier, a new paradigm in cancer biology</article-title><source> Cancer Res</source><year>2014</year><volume>74</volume><fpage>8</fpage><lpage>14</lpage><pub-id pub-id-type="pmid">24362915</pub-id></element-citation></ref><ref id="B44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petit</surname><given-names>F</given-names></name><name><surname>Jarrous</surname><given-names>A</given-names></name><name><surname>Dickinson</surname><given-names>RD</given-names></name><name><surname>Molina</surname><given-names>PE</given-names></name><name><surname>Abumrad</surname><given-names>N</given-names></name><name><surname>Lang</surname><given-names>CH</given-names></name></person-group><article-title>Contribution of central &#x00026; peripheral adrenergic stimulation to IL-1 alpha-mediated glucoregulation</article-title><source> Am J Physiol</source><year>1994</year><volume>267</volume><fpage>E49</fpage><lpage>56</lpage><pub-id pub-id-type="pmid">8048512</pub-id></element-citation></ref><ref id="B45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McNamee</surname><given-names>EN</given-names></name><name><surname>Ryan</surname><given-names>KM</given-names></name><name><surname>Kilroy</surname><given-names>D</given-names></name><name><surname>Connor</surname><given-names>TJ</given-names></name></person-group><article-title>Noradrenaline induces IL-1ra and IL-1 type II receptor expression in primary glial cells and protects against IL-1beta-induced neurotoxicity</article-title><source> Eur J Pharm</source><year>2010</year><volume>626</volume><fpage>219</fpage><lpage>228</lpage></element-citation></ref><ref id="B46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McNamee</surname><given-names>EN</given-names></name><name><surname>Griffin</surname><given-names>EW</given-names></name><name><surname>Ryan</surname><given-names>KM</given-names></name><name><surname>Ryan</surname><given-names>KJ</given-names></name><name><surname>Heffernan</surname><given-names>S</given-names></name><name><surname>Harkin</surname><given-names>A</given-names></name><etal/></person-group><article-title>Noradrenaline acting at beta adrenoceptors induces expression of IL-1beta and its negative regulators IL-1ra and IL-1RII, and drives an overall anti-inflammatory phenotype in rat cortex</article-title><source> Neuropharmacol</source><year>2010</year><volume>59</volume><fpage>37</fpage><lpage>48</lpage></element-citation></ref><ref id="B47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ojeda-Ojeda</surname><given-names>M</given-names></name><name><surname>Murri</surname><given-names>M</given-names></name><name><surname>Insenser</surname><given-names>M</given-names></name></person-group><article-title>Mediators of low-grade chronic inflammation in polycystic ovary syndrome (PCOS)</article-title><source> Curr Pharm Des</source><year>2013</year><volume>19</volume><fpage>5775</fpage><lpage>5791</lpage><pub-id pub-id-type="pmid">23448487</pub-id></element-citation></ref><ref id="B48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scanzano</surname><given-names>A</given-names></name><name><surname>Cosentino</surname><given-names>M</given-names></name></person-group><article-title>Adrenergic regulation of innate immunity: a review</article-title><source> Front Pharmacol</source><year>2015</year><volume>6</volume><fpage>171</fpage><pub-id pub-id-type="pmid">26321956</pub-id></element-citation></ref><ref id="B49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luotola</surname><given-names>K</given-names></name><name><surname>Piltonen</surname><given-names>TT</given-names></name><name><surname>Puurunen</surname><given-names>J</given-names></name><name><surname>Tapanainen</surname><given-names>JS</given-names></name></person-group><article-title>IL-1 receptor antagonist levels are associated with glucose tolerance in polycystic ovary syndrome</article-title><source> Clin Endocrinol (Oxf)</source><year>2016</year><volume>85</volume><fpage>430</fpage><lpage>435</lpage><pub-id pub-id-type="pmid">27061312</pub-id></element-citation></ref><ref id="B50"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martoriati</surname><given-names>A</given-names></name><name><surname>Caillaud</surname><given-names>M</given-names></name><name><surname>Goudet</surname><given-names>G</given-names></name><name><surname>G&#x000e9;rard</surname><given-names>N</given-names></name></person-group><article-title>Inhibition of in vitro maturation of equine oocytes by interleukin 1 beta via specific IL-1 receptors</article-title><source> Reproduction</source><year>2003</year><volume>126</volume><fpage>509</fpage><lpage>515</lpage><pub-id pub-id-type="pmid">14525533</pub-id></element-citation></ref><ref id="B51"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bosmann</surname><given-names>M</given-names></name><name><surname>Meta</surname><given-names>F</given-names></name><name><surname>Ruemmler</surname><given-names>R</given-names></name></person-group><article-title>Regulation of IL-17 family members by adrenal hormones during experimental sepsis in mice</article-title><source> Am J Pathol</source><year>2013</year><volume>182</volume><fpage>1124</fpage><lpage>1130</lpage><pub-id pub-id-type="pmid">23499051</pub-id></element-citation></ref><ref id="B52"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lomax</surname><given-names>A</given-names></name><name><surname>Chisholm</surname><given-names>S</given-names></name><name><surname>Nagpal</surname><given-names>S</given-names></name><name><surname>Cervi</surname><given-names>A</given-names></name></person-group><article-title>Remodelling of the sympathetic nervous system following inflammation</article-title><source> FASEB J</source><year>2011</year><volume>25</volume><fpage>304</fpage><lpage>304</lpage></element-citation></ref></ref-list></back></article>